Why is P & G Health Ltd falling/rising?

As of 24-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,304.60, reflecting an increase of 19.65 (0.31%). The stock has shown a positive trend recently, gaining for the last two days with a total return of 0.8% during this period. Despite a slight decline of 0.40% over the past week and a 4.10% drop in the last month, the stock has performed well year-to-date with a return of 20.55%. Key factors contributing to this upward movement include high management efficiency indicated by a return on equity (ROE) of 32.32%, a low debt-to-equity ratio, and consistent positive results over the last four quarters. However, there are concerns regarding poor long-term growth, as net sales have only grown at an annual rate of 7.39% over the last five years.
In the broader market context, the stock has outperformed the benchmark Sensex in the long term, generating a return of 17.74% over the past year compared to the Sensex's decline of 3.77%. While the stock has shown resilience and strong institutional support, with holdings at 21.15%, it has faced challenges in short-term performance relative to the benchmark, particularly with a recent decline in investor participation as indicated by a drop in delivery volume. Overall, the stock's recent rise can be attributed to its strong fundamentals and management efficiency, despite some concerns about long-term growth prospects.